Detalhe da pesquisa
1.
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet;
403(10434): 1341-1350, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38521086
2.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med;
385(20): 1856-1867, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34534429
3.
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Gynecol Oncol;
178: 119-129, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37862791
4.
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer.
Int J Gynecol Cancer;
30(7): 1034-1042, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32527769
5.
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
Lancet Oncol;
18(11): 1483-1492, 2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28967485
6.
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
JAMA Oncol;
10(2): 185-192, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38095881
7.
Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
BJU Int;
112(1): 13-25, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23356411
8.
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib.
AJR Am J Roentgenol;
200(1): 120-6, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23255750
9.
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
J Clin Oncol;
41(36): 5505-5511, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37910822
10.
The expanding role of bevacizumab in the treatment of human epidermal growth factor receptor 2-negative breast cancer.
Curr Oncol Rep;
12(1): 22-5, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20425604
11.
Reply to P.-H. Luo et al.
J Clin Oncol;
42(13): 1596-1598, 2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38452314
12.
Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma.
Cancer Manag Res;
7: 65-73, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25709499
13.
Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database.
Cancer Epidemiol Biomarkers Prev;
24(1): 303-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25389114
14.
On the importance of heterogeneity in meta-analysis.
Clin Trials;
6(5): 443-4; discussion 445, 2009 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19846896
15.
Management of sorafenib-related adverse events: a clinician's perspective.
Semin Oncol;
41 Suppl 2: S1-S16, 2014 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24576654
16.
Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
Cancer Biol Ther;
15(6): 683-7, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24618718
17.
Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.
Diabetes Care;
37(7): 1910-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24496803
18.
Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
Int J Radiat Oncol Biol Phys;
88(3): 603-10, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24411628
19.
The molecular biology of renal cell carcinoma.
Semin Oncol;
40(4): 421-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23972705
20.
A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Int J Radiat Oncol Biol Phys;
85(1): 81-8, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22543204